The study methodologies used to examine the Oncolytic Virus Therapy market for the forecast period, 2020 - 2027 further classifies the industry by type, geography, end-use and end-user to add more precision and bring to light factors responsible for augmenting business development.

Vancouver, BC -- (SBWire) -- 03/09/2021 --The global oncolytic virus therapy market size is expected to reach USD 866.1 Million at a steady CAGR of 23.9% in 2028, according to latest analysis by Emergen Research. Steady growth of oncolytic virus therapy market can be attributed to rising cancer incidence globally. Cancer is a major cause of deaths in countries across the globe and it is estimated that in 2020, over 1.8 million new cancer cases were diagnosed in the US, with over 0.6 Million deaths occurring due to the disease. Also, around 70% of cancer mortality occurs in low and middle-income countries. Oncolytic virus therapy (a type of immunotherapy) uses engineered viruses to destroy cancer cells without affecting healthy cells in the human body. Once a cancer cell is destroyed, it releases cancer antigens that trigger immune responses to destroy other tumor cells in the body.

Significant driving forces shaping the future of the Oncolytic Virus Therapy market for the forecast period 2020 - 2027 find a special mention in the study and are backed by a real-time statistics. Thorough segmentation of the industry by type, application, classification, and geography works as an impetus towards increasing the sale figures and boosting business prospects alongside the hindrances that often restrict the industry's growth. In addition, bifurcation of the market on the basis of consumption volume, customer preference, end-user, and production capacity is explained through important resources including but not limited to charts, graphic images, and tables.

You Can Download Free Sample PDF Copy of Oncolytic Virus Therapy Market at https://www.emergenresearch.com/request-sample/541

Here are the questions we answer...
What are the future opportunities in store for the vendors operating in the Oncolytic Virus Therapy market?
What does the competitive landscape look like?
Which emerging technologies are believed to impact the Oncolytic Virus Therapy market performance?
What are the key trends and dynamics?
Which regulations that will impact the industry?
Which segment will offer the most opportunity for growth between 2020 and 2027?
Where will most developments take place in the long term?
Who are the most prominent vendors and how much market share do they occupy?
What are the latest technologies or discoveries influencing the Oncolytic Virus Therapy market growth worldwide?

Market Segments
The global Oncolytic Virus Therapy market has been categorized based on the product type, application, and region. Our expert analysts undertake a thorough assessment of all of the segments included in the report and analyze them based on their market share, revenue, market growth rate, and other vital factors. The segmentation allows the interested parties to determine sectors in the global Oncolytic Virus Therapy market with high growth prospects and understand the growth strategies adopted by leading segments during the forecast period.

You Can Download Free Sample PDF Copy of Oncolytic Virus Therapy Market at https://www.emergenresearch.com/request-sample/541

Some Key Highlights in the Report
In October 2020, Oncolytics Biotech made announced the signing of a partnership agreement with AIO and Roche to commence a Phase ½ trial(GOBLET) for gastrointestinal cancer. The trial would examine the use of pelareorep with anti-PD-L1 checkpoint inhibitor by Roche in cancer patients.
Monoclonal antibodies are considered beneficial in stimulating immune responses to destroy cancer cells. In addition, certain monoclonal antibodies are capable of blocking the connection between the cellular growth promoting proteins and cancer cells, thereby killing the cancer cells.
Oncolytic virus therapy in the treatment of lung cancer is used to deliver specific immunomodulatory or therapeutic genes to destroy cancer cells. Oncolytic virus therapy holds significant potential to improve tumor cell oncolysis and circumvent resistance mechanisms of tumor cells. It was estimated that in 2020, over 0.2 million adults in the US were diagnosed with lung cancer, which accounted for around 13.0% of the total individuals diagnosed with cancer in the same year.
The North America oncolytic virus therapy accounted for largest revenue share in the global oncolytic virus therapy market in 2020, which can be attributed to rising incidence of cancer, particularly among the elderly population. Furthermore, presence of major oncolytic virus therapy firms and rising investments in cancer immunotherapy is a major factor driving growth of the market in the region.
Key players in the market include Oncolytics Biotech Inc., Lokon Pharma AB, PsiOxus Therapeutics, Sorrento Therapeutics Inc., CG Oncology Inc., ORYX GmbH & Co. KG, VCNBiosciences, DNAtrix, Targovax, and SillaJen Inc.

Type Outlook (Revenue, USD Million; 2021–2028)
Monoclonal Antibodies
Checkpoint Inhibitors
Cancer Vaccines
Immunomodulators

Application Outlook (Revenue, USD Million; 2021–2028)
Melanoma
Lung Cancer
Breast Cancer
Others

End-Use Outlook (Revenue, USD Million; 2021–2028)
Hospitals
Clinics
Research Institutes
Others

Regional Outlook (Revenue: USD Billion; Volume: Million MT; 2017-2027)
North America
Europe
Asia Pacific
Latin America
MEA

Read more@ https://www.emergenresearch.com/industry-report/oncolytic-virus-therapy-market

Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Oncolytic Virus Therapy Market Segmentation & Impact Analysis
Chapter 5. Oncolytic Virus Therapy Market By Technology Insights & Trends, Revenue (USD Billion) (Million MT)
Chapter 6. Oncolytic Virus Therapy Market By End-Use Verticals Insights & Trends Revenue (USD Billion) (Million MT)
Chapter 7. Oncolytic Virus Therapy Market Regional Outlook
Continued…